BRIEF-Akari Therapeutics says Edison Investment has withdrawn report titled "Akari's coversin matches soliris in phase II"
April 27 Akari Therapeutics Plc
* Akari therapeutics plc says edison investment research ltd has withdrawn the report titled "akari's coversin matches soliris in phase ii" Source text for Eikon: Further company coverage:
UPDATE 1-Property markets outlook remains strong as golden age fades -PGIM
NEW YORK, June 27 A golden period in global property markets appears near an end as rising interest rates and lower returns hurt performance, but the outlook for real estate remains strong, asset manager PGIM said on Tuesday.